Press Releases
PRESS RELEASE
MolecuLight Announces Strategic Alliance with Tissue Analytics to Integrate its MolecuLight...
PRESS RELEASE
MolecuLight Announces Industry Partnership and Virtual Exhibit of its MolecuLight i:X®...
PRESS RELEASE
First Published Study to Report In Vitro Detection of Fluorescence from Bacteria in...
PRESS RELEASE
New MolecuLight i:X® Upgrade Enables Faster, More Accurate Digital Wound Measurement
PRESS RELEASE
SDVOSB Maness Veteran Medical Partners with MolecuLight to Distribute its i:X® Real-Time...
PRESS RELEASE
American Medical Association Issues Category lll CPT Code for Real-time Fluorescence Wound...
PRESS RELEASE
University Hospitals Ahuja Medical Center Physician First in Ohio to Use Wound Care Imaging...
PRESS RELEASE
AMA Announces Approval for Category lll CPT Code for Real-time Fluorescence Wound Imaging
Archive
2019
— PRESS RELEASE
Clinical Results from the MolecuLight i:X® Fluorescence Imaging System are Featured in Two Clinical Talks and Seven Posters at the SAWC Fall 2019 Annual Conference
— PRESS RELEASEResults from Clinical Studies using MolecuLight i:X® Fluorescence Imaging System Featured Prominently at the Wounds Canada 2019 Annual Conference
— PRESS RELEASEPublished Study Finds 9/10 Chronic Wound Patients Likely to Have Received More Appropriately Triaged Care with Information from the MolecuLight i:X® Imaging Device
— PRESS RELEASEOxford Finance LLC Provides $7.5M USD Term Loan to MolecuLight® Inc. to Support Global Commercial Expansion
— PRESS RELEASEphotonamic GmbH & Co. KG (Germany) Acquires the Oncology Business from MolecuLight® Inc. (Canada)
2018
— PRESS RELEASE
MolecuLight® Inc.’s first-of-its-kind handheld fluorescence imaging device receives FDA De Novo clearance for US wound care market
— NEWSMolecuLight® partners with SerenaGroup for a multi-center clinical trial
— NEWSMolecuLight clinical insights from EWMA 2018
— NEWSNew Publication: Efficacy of an imaging device at identifying the presence of bacteria in wounds at a plastic surgery outpatients clinic
2017
— BLOG
The role of the MolecuLight i:X in potential improvement of current debridement practices
— PRESS RELEASEMolecuLight announces appointment of Anil Amlani as CEO
— BLOGPredicting the presence of pathogenic bacteria in wounds
— BLOGFish skin for human wounds: Iceland’s pioneering treatment
— NEWSNew Publication: Predicting the presence of pathogenic bacteria in wounds
— NEWSRose Raizman receives EWMA e-poster prize
— NEWSImproving antimicrobial stewardship practices with the MolecuLight i:X
— NEWSHow will fluorescence imaging impact wound care?
— NEWSEWMA 2017 update
— NEWSThe use of MolecuLight i:X in managing burns
— NEWSMolecuLight at SAWC Spring 2017
— NEWSMolecuLight i:X featured in the Toronto Star.
— NEWSMolecuLight i:X performs better than Levine method to maximize sampling of treatment-relevant pathogens in chronic wounds.
— BLOGWill the ‘urgent need’ for new drugs be sufficient in the fight against bacteria?
— NEWSThe MolecuLight i:X a novel solution in the ever-increasing battle against antibiotic resistance?
— BLOGAntibiotic resistance continues to be a real issue
2016
— BLOG
